Soc. Generale Bonus Zert MRK 28.0.../ DE000SV7SM34 /
5/23/2024 1:12:43 PM | Chg.+2.190 | Bid5/23/2024 | Ask5/23/2024 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
169.480EUR | +1.31% | 169.480 Bid Size: 2,000 |
169.540 Ask Size: 2,000 |
MERCK KGAA O.N. | - EUR | 6/28/2024 | Call |
GlobeNewswire
1:00 PM
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
1:00 PM
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
5/7
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
5/6
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
3/4
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
12/21/2023
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
12/14/2023
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
10/17/2023
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA